These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 8373001)

  • 1. Hepatitis associated with high dose intravenous gammaglobulin.
    Craig TJ; Davis W
    Ann Allergy; 1993 Sep; 71(3):276. PubMed ID: 8373001
    [No Abstract]   [Full Text] [Related]  

  • 2. Acute myocardial infarction following intravenous immunoglobulin therapy for chronic inflammatory demyelinating polyneuropathy in association with a monoclonal immunoglobulin G paraprotein.
    Stamboulis E; Theodorou V; Kilidireas K; Apostolou T
    Eur Neurol; 2004; 51(1):51. PubMed ID: 14639034
    [No Abstract]   [Full Text] [Related]  

  • 3. New liquid intravenous immunoglobulin (10 % IVIg) for treatment of multifocal motor neuropathy: a prospective study of efficacy, safety and tolerability.
    Cats EA; van der Pol WL; Piepers S; Notermans NC; van den Berg-Vos RM; van den Berg LH
    J Neurol; 2008 Oct; 255(10):1598-9. PubMed ID: 18758888
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunoglobulins in chronic inflammatory demyelinating polyneuropathy.
    Comi G; Quattrini A; Fazio R; Roveri L
    Neurol Sci; 2003 Oct; 24 Suppl 4():S246-50. PubMed ID: 14598053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Intravenous IgG for treatment of neuromuscular diseases].
    Vedeler CA; Mellgren SI; Omdal R; Torbergsen T; Aasly J
    Tidsskr Nor Laegeforen; 2010 Sep; 130(17):1717-20. PubMed ID: 20835282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strokes after intravenous gamma globulin: thrombotic phenomenon in patients with risk factors or just coincidence?
    Alexandrescu DT; Dutcher JP; Hughes JT; Kaplan J; Wiernik PH
    Am J Hematol; 2005 Mar; 78(3):216-20. PubMed ID: 15726606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatocellular injury and hematologic cytopenia after high-dose intravenous immunoglobulin administration.
    Yuan HL; Yang TC; Zhang W; Wu ZM
    Clin Toxicol (Phila); 2018 Dec; 56(12):1208-1210. PubMed ID: 29889569
    [No Abstract]   [Full Text] [Related]  

  • 8. Intravenous immunoglobulin induced meningoencephalitis.
    Nooraine J; Iyer RB; Raghavendra S
    Neurol India; 2014; 62(1):98-9. PubMed ID: 24608480
    [No Abstract]   [Full Text] [Related]  

  • 9. Safety and tolerability of intravenous immunoglobulins.
    Martin TD
    Electroencephalogr Clin Neurophysiol Suppl; 1999; 50():514-20. PubMed ID: 10689502
    [No Abstract]   [Full Text] [Related]  

  • 10. [A case of recurrent aseptic meningitis caused by high-dose intravenous gammaglobulin therapy for chronic inflammatory demyelinating polyneuropathy].
    Kato T; Suzuki E; Sone M; Yoshida E; Hirayama M
    Rinsho Shinkeigaku; 2001 Nov; 41(11):797-800. PubMed ID: 12080612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The treatment of demyelinating polyneuropathies of different origins with small doses of immunoglobulin G].
    Popova LM; Avdiunina IA
    Zh Nevrol Psikhiatr Im S S Korsakova; 1997; 97(5):27-9. PubMed ID: 9245154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current treatments of chronic immune-mediated demyelinating polyneuropathies.
    Brannagan TH
    Muscle Nerve; 2009 May; 39(5):563-78. PubMed ID: 19301378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclosporin treatment in three children with chronic inflammatory demyelinating neuropathy.
    Hergüner MO; Incecik F; Altunbaşak S
    Pediatr Neurol; 2009 Sep; 41(3):223-5. PubMed ID: 19664543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatotoxicity after high-dose methylprednisolone for demyelinating disease.
    Loraschi A; Banfi P; Mauri M; Sessa F; Bono G; Cosentino M
    Clin Neuropharmacol; 2010; 33(1):52-4. PubMed ID: 19935411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human polyvalent immunoglobulin: new indication. Multifocal motor neuropathy: slightly more muscle strength. Improvement in muscle strength, but frequent hypersensitivity reactions.
    Prescrire Int; 2009 Apr; 18(100):62. PubMed ID: 19585721
    [No Abstract]   [Full Text] [Related]  

  • 16. [High-dose intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy].
    Tomiyama M; Baba M; Matsunaga M; Takada H; Okushima T; Narita S; Takebe K
    No To Shinkei; 1992 Nov; 44(11):979-82. PubMed ID: 1296721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The clinical usefulness of high-dose intravenous immunoglobulin therapy for chronic inflammatory demyelinating polyneuropathy and multifocal motor neuropathy].
    Kubori T; Mezaki T; Kaji R; Kimura J; Hamaguchi K; Hirayama K; Kanazawa I; Miyatake T; Mannen T; Kowa H; Yanagisawa N; Goto I; Osame M; Kanda M; Tashiro K; Baba M; Kuroiwa Y; Nagatomo H; Mitsuma T; Shigeta Y; Saida T; Nakajima K; Kawamura J; Murai Y; Kiuchi T
    No To Shinkei; 1999 Feb; 51(2):127-35. PubMed ID: 10198901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Acute hepatitis caused by isaxonine phosphate. 2 cases].
    Espinoza P; Pelletier G; Attali P; Sinico M; Ladouch A
    Gastroenterol Clin Biol; 1983 Nov; 7(11):936-7. PubMed ID: 6689158
    [No Abstract]   [Full Text] [Related]  

  • 19. High-dose intravenous immunoglobulin therapy in dysimmune neuropathies.
    Nobile-Orazio E; Bersano A
    Neurol Sci; 2002 Apr; 23 Suppl 1():S25-32. PubMed ID: 12032584
    [No Abstract]   [Full Text] [Related]  

  • 20. Role of activity-dependent conduction block in the diagnosis of primary demyelinating polyneuropathy.
    Salameh JS; Souayah N; Chong PS
    J Clin Neuromuscul Dis; 2012 Sep; 14(1):40-4. PubMed ID: 22922581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.